Genesis IBRC India [GENESIS] vs Biocon [BIOCON] Detailed Stock Comparison
Genesis IBRC India
BSE
Loading...
Biocon
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Genesis IBRC India wins in 8 metrics, Biocon wins in 10 metrics, with 0 ties. Biocon appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Genesis IBRC India | Biocon | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 29.47 | 109.74 | Genesis IBRC India |
| Price-to-Book Ratio | 10.23 | 1.95 | Biocon |
| Debt-to-Equity Ratio | 0.00 | 66.26 | Genesis IBRC India |
| PEG Ratio | 1.03 | -1.15 | Biocon |
| EV/EBITDA | 29.57 | 19.24 | Biocon |
| Profit Margin (TTM) | 94.96% | 2.44% | Genesis IBRC India |
| Operating Margin (TTM) | 94.96% | 7.46% | Genesis IBRC India |
| EBITDA Margin (TTM) | 94.96% | 7.46% | Genesis IBRC India |
| Return on Equity | 41.08% | 3.66% | Genesis IBRC India |
| Return on Assets (TTM) | 39.67% | 1.72% | Genesis IBRC India |
| Free Cash Flow (TTM) | $-3,000 | $17.18B | Biocon |
| Dividend Yield | N/A | 0.26% | N/A |
| 1-Year Return | 330.64% | 1.70% | Genesis IBRC India |
| Price-to-Sales Ratio (TTM) | 28.00 | 2.98 | Biocon |
| Enterprise Value | $1.04B | $620.67B | Biocon |
| EV/Revenue Ratio | 28.26 | 3.94 | Biocon |
| Gross Profit Margin (TTM) | N/A | 64.06% | N/A |
| Revenue per Share (TTM) | $3 | $131 | Biocon |
| Earnings per Share (Diluted) | $2.68 | $3.21 | Biocon |
| Beta (Stock Volatility) | 0.54 | 0.25 | Biocon |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Genesis IBRC India vs Biocon Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Genesis IBRC India | 5.00% | 21.53% | 107.62% | 272.20% | 330.64% | 330.64% |
| Biocon | -1.28% | 3.94% | -2.57% | -5.93% | 1.88% | -4.49% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Genesis IBRC India | 330.64% | 330.64% | 907.40% | 907.40% | 907.40% | 907.40% |
| Biocon | 1.70% | 24.54% | -22.05% | 376.72% | 414.31% | 787.95% |
News Based Sentiment: Genesis IBRC India vs Biocon
Genesis IBRC India
News based Sentiment: POSITIVE
Genesis IBRC India Ltd. experienced a remarkably positive month, achieving new all-time highs and demonstrating exceptional growth across multiple timeframes. The company's strong financial performance, coupled with its zero debt status, significantly strengthens its investment appeal and positions it for continued success.
Biocon
News based Sentiment: MIXED
October was a pivotal month for Biocon, marked by a significant U.S. market entry with its biosimilars, alongside concerning financial results and valuation concerns. While the launch presents a long-term growth opportunity, the current financial performance and high valuation create a mixed investment picture.
Performance & Financial Health Analysis: Genesis IBRC India vs Biocon
| Metric | GENESIS | BIOCON |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.03B | ₹470.24B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 1 | 1,896,179 |
| 90 Day Avg. Volume | 4 | 2,533,957 |
| Last Close | ₹78.98 | ₹347.75 |
| 52 Week Range | ₹15.85 - ₹78.98 | ₹291.00 - ₹406.00 |
| % from 52W High | 0.00% | -14.35% |
| All-Time High | ₹78.98 (Oct 03, 2025) | ₹487.75 (Dec 21, 2020) |
| % from All-Time High | 0.00% | -28.70% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.15% |
| Quarterly Earnings Growth | N/A | -0.95% |
| Financial Health | ||
| Profit Margin (TTM) | 0.95% | 0.02% |
| Operating Margin (TTM) | 0.95% | 0.07% |
| Return on Equity (TTM) | 0.41% | 0.04% |
| Debt to Equity (MRQ) | 0.00 | 66.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹7.72 | ₹180.66 |
| Cash per Share (MRQ) | ₹0.00 | ₹38.10 |
| Operating Cash Flow (TTM) | ₹0 | ₹17.78B |
| Levered Free Cash Flow (TTM) | ₹35.05M | ₹10.13B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.26% |
| Last 12-Month Dividend | N/A | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Genesis IBRC India vs Biocon
| Metric | GENESIS | BIOCON |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 29.47 | 109.74 |
| Forward P/E | N/A | 35.51 |
| PEG Ratio | 1.03 | -1.15 |
| Price to Sales (TTM) | 28.00 | 2.98 |
| Price to Book (MRQ) | 10.23 | 1.95 |
| Market Capitalization | ||
| Market Capitalization | ₹1.03B | ₹470.24B |
| Enterprise Value | ₹1.04B | ₹620.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 28.26 | 3.94 |
| Enterprise to EBITDA | 29.57 | 19.24 |
| Risk & Other Metrics | ||
| Beta | 0.54 | 0.25 |
| Book Value per Share (MRQ) | ₹7.72 | ₹180.66 |
Financial Statements Comparison: Genesis IBRC India vs Biocon
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GENESIS | BIOCON |
|---|---|---|
| Revenue/Sales | ₹0 | ₹39.10B |
| Cost of Goods Sold | N/A | ₹14.05B |
| Gross Profit | N/A | ₹25.05B |
| Research & Development | N/A | ₹-346.00M |
| Operating Income (EBIT) | ₹-1.18M | ₹2.94B |
| EBITDA | ₹-1.18M | ₹8.29B |
| Pre-Tax Income | ₹-1.18M | ₹969.00M |
| Income Tax | ₹0 | ₹77.00M |
| Net Income (Profit) | ₹-1.18M | ₹892.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GENESIS | BIOCON |
|---|---|---|
| Cash & Equivalents | ₹57,000 | ₹32.27B |
| Total Current Assets | ₹88.35M | ₹162.86B |
| Total Current Liabilities | ₹3.03M | ₹143.34B |
| Long-Term Debt | N/A | ₹129.45B |
| Total Shareholders Equity | ₹85.33M | ₹277.13B |
| Retained Earnings | ₹-83.06M | ₹189.59B |
| Property, Plant & Equipment | N/A | ₹4.32B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GENESIS | BIOCON |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GENESIS | BIOCON |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1 | 1,896,179 |
| Average Daily Volume (90 Day) | 4 | 2,533,957 |
| Shares Outstanding | 13.00M | 1.20B |
| Float Shares | 577,640 | 524.74M |
| % Held by Insiders | 0.96% | 0.55% |
| % Held by Institutions | 0.00% | 0.24% |
Dividend Analysis & Yield Comparison: Genesis IBRC India vs Biocon
| Metric | GENESIS | BIOCON |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.00 |
| Last 12-Month Dividend Yield | N/A | 0.26% |
| 3-Year Avg Annual Dividend | N/A | ₹1.33 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | ₹4.00 |
| Ex-Dividend Date | N/A | Jul 04, 2025 |